Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$146.87
▼ $0.28 (−0.19%) today
Markets closed · 5:53am ET

MRK Coverage

Page 40
4:01pm ET
Investing

Merck Dominates DJIA Boost Friday

August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial and tech sectors led the gainers today, the former likely on improved…

Paul Ausick
10:50am ET
Investing

Top Dow Earnings for the Week Ahead

Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the run that the Dow has made since the Brexit vote.

Chris Lange
4:01pm ET
Investing

The 4 Stocks That Lifted the DJIA Wednesday

July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a new 31-year low against the dollar before climbing back a little. The…

Paul Ausick
7:38am ET
Health and Healthcare

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity…

Chris Lange
4:01pm ET
Investing

The 4 Stocks That Boosted the Dow Wednesday

June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell approaches. A drawdown in U.S. crude oil inventories coupled with a weaker…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Tanked the Dow on Friday

June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Lifted the Dow on Thursday

June 16, 2016: Markets opened lower Thursday but equities showed some spunk by trading on an upward trend for nearly the whole day. Asian and European markets traded lower and economics data…

Paul Ausick
11:05am ET
Health and Healthcare

Merck Moves to Acquire Afferent Pharma

Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.

MRK
Chris Lange